Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

David Gurwitz*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

633 Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science